Also, the amount has increased from INR 20Cr to INR 40-45Cr. However, the company has taken the legal action against them and does not foresee any financial implication.
Posts in category Value Pickr
Tara Chand Infralogistic Solutions Ltd (17-04-2024)
Gross block before the new capex is Rs. 236 Cr as on FY23.
Microcap momentum portfolio (17-04-2024)
@vishweshwar_kadiyala You have to pull the daily closing price. Then calculate the 6 months or 1 year return. The other thing we do is the calculation of daily price change using this info. We have to use the last 6m or 1 year data to calculate the standard deviation.
Please see below. This is how the table will look. We have to do this for all stocks in the index.
AARTIDRUGS | ||
---|---|---|
27/03/2024 | 440.80 | -0.236% |
28/03/2024 | 434.30 | -0.645% |
01/04/2024 | 457.40 | 2.251% |
02/04/2024 | 468.20 | 1.014% |
03/04/2024 | 474.70 | 0.599% |
04/04/2024 | 487.75 | 1.178% |
05/04/2024 | 492.65 | 0.434% |
08/04/2024 | 487.30 | -0.474% |
09/04/2024 | 513.05 | 2.236% |
10/04/2024 | 508.00 | -0.430% |
12/04/2024 | 504.20 | -0.326% |
Dreamfolks services limited( DFS) (17-04-2024)
Agreed. But they are also diversifying their revenues. Railway Lounges (which is an even bigger market than airport lounges plus Govt plans to make Railways better) and Golf Services, Salon Services etc etc as mentioned in my Blog Post.
Security and Intelligence Services (India) Limited (17-04-2024)
Why is the market not giving premium to the stock price, despite such good revenue growth?
Ganesh Benzoplast – Cash rich chemical storage/tank king (17-04-2024)
https://www.screener.in/company/GANESHBE/
As per the above disclosure, Mr Ramakant Pilani is involved in the fraud reported earlier by the company on 2nd April 2024.
It is a serious red flag in my opinion.
Natco Pharma: Focusing On Complex Products (17-04-2024)
Natco Pharma Limited – 672564 – 04/08/2024 Natco Pharma Limited – 672564 – 04/08/2024 | FDA
Contents of warning letter is in public domain
In its response to the usfda Natco had volunteered to suspend drug production/supplies from kothur plant to US market which has been accepted and conveyed in the WL… this should be read in the context of companys disclosure to the bourses earlier on this subject… Here is hoping that the two strengths of Lenalidomide that it didn’t have dual clearance for( in the vizag facility) have been subsequently cleared since…
Sunteck Realty – Quality Real Estate Company (16-04-2024)
(post deleted by author)
GMM Pfaudler: A safe way to play the Pharma/Chemical cycle (16-04-2024)
Can you please share your CAGR calculations? As per me if earnings is growing from 256CR to 456CR over 3 years it is a 21.22% CAGR, so assuming PE remains same at 33 the share price growth should be the same right?